Jpmorgan Chase & CO Lifevantage Corp Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Lifevantage Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 517 shares of LFVN stock, worth $4,606. This represents 0.0% of its overall portfolio holdings.
Number of Shares
517
Previous 997
48.14%
Holding current value
$4,606
Previous $17,000
58.82%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LFVN
# of Institutions
117Shares Held
6.95MCall Options Held
0Put Options Held
42.5K-
Capital Management Corp1.27MShares$11.3 Million3.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny894KShares$7.97 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA564KShares$5.03 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT446KShares$3.98 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX293KShares$2.61 Million0.0% of portfolio
About Lifevantage Corp
- Ticker LFVN
- Exchange NASDAQ
- Sector Consumer Defensive
- Industry Packaged Foods
- Shares Outstandng 12,560,000
- Market Cap $112M
- Description
- LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...